Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
i3 Verticals, Inc. stock logo
IIIV
i3 Verticals
$26.43
+2.8%
$25.25
$20.42
$29.80
$878.09M1.22252,898 shs726,700 shs
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
$7.18
+0.3%
$7.77
$6.08
$19.12
$924.03M1.651.28 million shs2.34 million shs
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
$13.64
+7.8%
$11.68
$3.78
$15.71
$252.27M1.34299,427 shs439,389 shs
Willdan Group, Inc. stock logo
WLDN
Willdan Group
$62.30
+0.2%
$49.94
$28.57
$62.82
$903.16M1.23147,506 shs702,565 shs
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
i3 Verticals, Inc. stock logo
IIIV
i3 Verticals
0.00%+7.35%+4.51%+7.48%+33.82%
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
0.00%+2.57%-2.58%-25.36%-45.93%
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
0.00%+5.90%+13.20%+57.87%+32.81%
Willdan Group, Inc. stock logo
WLDN
Willdan Group
0.00%+7.86%+16.01%+52.06%+123.62%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
i3 Verticals, Inc. stock logo
IIIV
i3 Verticals
4.2347 of 5 stars
2.41.00.03.32.24.22.5
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
4.0167 of 5 stars
4.25.00.00.02.03.30.6
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
1.6081 of 5 stars
2.41.00.00.04.01.70.6
Willdan Group, Inc. stock logo
WLDN
Willdan Group
3.8666 of 5 stars
1.83.00.04.13.42.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
i3 Verticals, Inc. stock logo
IIIV
i3 Verticals
2.86
Moderate Buy$29.5711.89% Upside
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
2.45
Hold$13.8392.66% Upside
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
2.73
Moderate Buy$10.81-20.73% Downside
Willdan Group, Inc. stock logo
WLDN
Willdan Group
3.50
Strong Buy$51.50-17.34% Downside

Current Analyst Ratings Breakdown

Latest OPRX, NEO, WLDN, and IIIV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/16/2025
i3 Verticals, Inc. stock logo
IIIV
i3 Verticals
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$33.00
6/9/2025
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$12.50 ➝ $16.00
5/15/2025
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral
5/13/2025
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/13/2025
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/13/2025
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform
5/13/2025
i3 Verticals, Inc. stock logo
IIIV
i3 Verticals
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$27.00 ➝ $25.00
5/13/2025
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$8.00 ➝ $12.50
5/13/2025
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetMarket Outperform ➝ Market Outperform$11.00 ➝ $14.00
5/6/2025
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetOverweight ➝ Overweight$18.00 ➝ $12.00
5/1/2025
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$17.00 ➝ $10.00
(Data available from 6/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
i3 Verticals, Inc. stock logo
IIIV
i3 Verticals
$229.92M3.82$1.20 per share22.11$15.20 per share1.74
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
$660.57M1.40$0.44 per share16.37$7.03 per share1.02
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
$92.13M2.74N/AN/A$6.35 per share2.15
Willdan Group, Inc. stock logo
WLDN
Willdan Group
$565.80M1.60$3.10 per share20.12$16.59 per share3.76
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
i3 Verticals, Inc. stock logo
IIIV
i3 Verticals
$113.34M$4.406.0125.66N/A46.46%3.15%2.00%8/6/2025 (Estimated)
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
-$78.73M-$0.61N/A79.78N/A-11.54%-2.21%-1.22%8/4/2025 (Estimated)
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
-$18.66M-$0.84N/AN/A4.55-16.33%-0.29%-0.20%8/6/2025 (Estimated)
Willdan Group, Inc. stock logo
WLDN
Willdan Group
$22.57M$1.6936.8631.31N/A4.08%13.74%6.98%7/30/2025 (Estimated)

Latest OPRX, NEO, WLDN, and IIIV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/12/2025Q1 2025
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
-$0.11$0.08+$0.19-$0.12$18.69 million$21.93 million
4/29/2025Q1 2025
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
-$0.02-$0.08-$0.06-$0.20$171.38 million$168.04 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
i3 Verticals, Inc. stock logo
IIIV
i3 Verticals
N/AN/AN/AN/AN/A
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
N/AN/AN/AN/AN/A
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
N/AN/AN/AN/AN/A
Willdan Group, Inc. stock logo
WLDN
Willdan Group
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
i3 Verticals, Inc. stock logo
IIIV
i3 Verticals
0.02
1.18
1.18
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
0.38
2.05
1.95
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
0.25
2.82
2.82
Willdan Group, Inc. stock logo
WLDN
Willdan Group
0.35
1.61
1.61

Institutional Ownership

CompanyInstitutional Ownership
i3 Verticals, Inc. stock logo
IIIV
i3 Verticals
84.22%
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
98.50%
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
76.47%
Willdan Group, Inc. stock logo
WLDN
Willdan Group
72.29%

Insider Ownership

CompanyInsider Ownership
i3 Verticals, Inc. stock logo
IIIV
i3 Verticals
59.07%
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
2.40%
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
5.60%
Willdan Group, Inc. stock logo
WLDN
Willdan Group
8.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
i3 Verticals, Inc. stock logo
IIIV
i3 Verticals
1,48033.22 million13.60 millionOptionable
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
2,200128.70 million125.61 millionOptionable
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
10018.50 million17.46 millionOptionable
Willdan Group, Inc. stock logo
WLDN
Willdan Group
1,76114.50 million13.25 millionOptionable

Recent News About These Companies

Willdan Group Expected To Stay On Current Growth Track

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
i3 Verticals stock logo

i3 Verticals NASDAQ:IIIV

$26.43 +0.73 (+2.84%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$27.02 +0.59 (+2.25%)
As of 06/27/2025 06:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

i3 Verticals, Inc. provides integrated payment and software solutions primarily to the public sector and healthcare markets in the United States. It operates in two segments, Software and Services, and Merchant Services. The company offers payment processing services that enables upper and lower court case management, collections, finance and accounting, motor vehicle and carrier registration, e-filing and taxation, license plate inventory, property tax management, utility billing, professional licensing, document workflow, and law enforcement software; assists public schools in completing payment processing functions, including accepting payments for online or at school lunches, and school activities. It also provides software platforms, such as electronic healthcare records and revenue cycle management solutions; insurance adjudication, patient engagement platforms, billing, scheduling, and integrated payments solutions; and workflow software and associated professional services to medical insurance payers. In addition, the company engages in software licenses and subscriptions, transaction-based fees, ongoing software maintenance and support, and other software-related solutions; and payment processing and gateway fees, as well as other related fixed transaction or service fees. Further, it sells equipment, and offers non-software related professional services. The company offers its solutions to clients through direct sales force; distribution partners comprising independent software vendors, independent sales organizations, and value-added resellers. i3 Verticals, Inc. was founded in 2012 and is headquartered in Nashville, Tennessee.

NeoGenomics stock logo

NeoGenomics NASDAQ:NEO

$7.18 +0.02 (+0.28%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$7.20 +0.02 (+0.21%)
As of 06/27/2025 04:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.

OptimizeRx stock logo

OptimizeRx NASDAQ:OPRX

$13.64 +0.99 (+7.83%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$13.65 +0.01 (+0.07%)
As of 06/27/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.

Willdan Group stock logo

Willdan Group NASDAQ:WLDN

$62.30 +0.13 (+0.21%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$62.32 +0.02 (+0.03%)
As of 06/27/2025 04:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Willdan Group, Inc., together with its subsidiaries, provides professional, technical, and consulting services primarily in the United States. It operates in two segments, Energy, and Engineering and Consulting. The Energy segment offers comprehensive audit and surveys, program design and implementation, master planning, demand reduction, grid optimization, benchmarking analyses, design engineering, construction management, performance contracting, installation, alternative financing, measurement and verification services, and software and data analytics, as well as energy consulting and engineering, turnkey facility and infrastructure projects, and customer support services. The Engineering and Consulting segment provides building and safety, city engineering and code enforcement, development plan review and inspection, disaster recovery, geotechnical and earthquake engineering, planning and surveying, contract staff support, program and construction management, structural engineering, transportation and traffic engineering, and water resources services. This segment also offers district administration, financial consulting, and federal compliance services. It serves public and governmental agencies, including cities, counties, redevelopment agencies, water districts, school districts, and universities; investor and municipal owned energy utilities; state and federal agencies; and commercial and industrial firms, as well as various other special districts and agencies. The company was founded in 1964 and is headquartered in Anaheim, California.